EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Ultrasensitive and highly specific detection of the Brucella genus and B . melitensis by CRISPR/Cas12b‐multiple cross displacement amplification technique

Sha Mao iD, Xinggui Yang iD, Yue Wang, Fengming Chen iD, Hai Jiang, Yi Wang iD, Yingqian Kang iD, Shijun Li iD

Journal of Clinical Microbiology · 2025

DOI: 10.1128/jcm.01532-24 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Clinical Microbiology, 2025. Verfasst von Sha Mao und 7 weiteren Autor:innen. Beteiligte Einrichtung: School of Public Health, the key Laboratory of Environmental Pollution Monitoring and Disease Control, Ministry of Education, Guizhou Medical Univers…. Hauptthemen laut MEDLINE: Brucellosis, Brucella, Brucella melitensis, Nucleic Acid Amplification Techniques. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Health Commission of Guizhou Province, National Disease Control and Prevention Administration.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Brucellosis is caused by members of the Brucella spp. and remains one of the world’s major zoonotic diseases. Brucella melitensis ( B. melitensis ) as the most contagious Brucella species cannot be ignored as an essential source of infection for brucellosis, especially in countries/regions dominated by animal husbandry. Thus, the identification of the Brucella genus and B. melitensis is crucial for rapid diagnosis of brucellosis to control disease transmission and clinical treatment. Here, we developed the CRISPR/Cas12b nuclease combined with a multiple cross displacement amplification (MCDA) assay (CRISPR-MCDA) for highly specific and sensitive detection of Brucella genus and B. melitensis in clinical applications. Two sets of specific primers were designed targeting the specific gene of Brucella genus ( Bcsp31 ) and B. melitensis ( BMEII0466 ), respectively. The CRISPR-MCDA assay showed high specificity and sensitivity in 28 non- Brucella isolates and 64 clinical samples. The detection limit of CRISPR-MCDA assay was 2 copies/μL in the plasmid dilution template, and the whole detection process took within 90 minutes with nanoparticle-based lateral flow biosensor (LFB) to validate experimental results. Taken together, the CRISPR-MCDA-LFB assay is a visual, sensitive, and highly specific detection technique that can be used as an attractive potential identification tool for Brucella genus and B. melitensis . IMPORTANCE The prevention and control of Brucellosis urgently require rapid and accurate diagnostic methods. This work validates a new method for the simultaneous detection of Brucella genus and B. melitensis . The method can effectively reduce the chances of contamination and provides a more rapid, sensitive, and specific on-site detection of Brucella . It also offers a solution for the rapid screening of Brucellosis in resource-limited environments, which is crucial for effective disease prevention and control. This technology can also be widely applied to the rapid detection of other pathogens beyond Brucella .

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

BrucellosisBrucellaBrucella melitensisNucleic Acid Amplification TechniquesCRISPR-Cas SystemsMolecular Diagnostic TechniquesSensitivity and SpecificityHumansAnimalsDNA Primers

Stichwörter der Autor:innen

B. melitensisBrucella genusCRISPRCas12bmultiple cross displacement amplification

Substanzen

DNA Primers

Autor:innen und Institutionen

  • School of Public Health, the key Laboratory of Environmental Pollution Monitoring and Disease Control, Ministry of Education, Guizhou Medical University, Guiyang, Guizhou, China.
  • Guizhou Center for Disease Control and Prevention, Guiyang, Guizhou, China.
  • Chinese Center for Disease Control and Prevention, Beijing, Beijing, China.
  • Experimental Research Center, Capital Children's Medical Center, Capital Medical University, Capital Institute of Pediatrics, Beijing, Beijing, China.
  • Molecular Diagnostics Center, Capital Children's Medical Center,Capital Medical University, Beijing, China.
  • School of Basic Medical Science and Institution of One Health Research, Guizhou Medical University, Guiyang, Guizhou, China.

ORCID-Profile: Sha Mao, Xinggui Yang, Fengming Chen, Yi Wang, Yingqian Kang, Shijun Li

Förderung

  • National Natural Science Foundation of China
  • Health Commission of Guizhou Province
  • National Disease Control and Prevention Administration
  • Foundation of Key Laboratory of Microbiology and Parasitology of Education Department of Guizhou

Zitieren

APA

Mao, S., Yang, X., Wang, Y., Chen, F., Jiang, H., Wang, Y., Kang, Y., & Li, S. (2025). Ultrasensitive and highly specific detection of the Brucella genus and B . melitensis by CRISPR/Cas12b‐multiple cross displacement amplification technique. Journal of Clinical Microbiology. https://doi.org/10.1128/jcm.01532-24

Vancouver

Mao S, Yang X, Wang Y, Chen F, Jiang H, Wang Y, et al. Ultrasensitive and highly specific detection of the Brucella genus and B . melitensis by CRISPR/Cas12b‐multiple cross displacement amplification technique. Journal of Clinical Microbiology. 2025. doi:10.1128/jcm.01532-24

BibTeX
@article{Mao2025,
  author = {Mao, Sha and Yang, Xinggui and Wang, Yue and Chen, Fengming and Jiang, Hai and Wang, Yi and Kang, Yingqian and Li, Shijun},
  title = {Ultrasensitive and highly specific detection of the Brucella genus and B . melitensis by CRISPR/Cas12b‐multiple cross displacement amplification technique},
  journal = {Journal of Clinical Microbiology},
  year = {2025},
  doi = {10.1128/jcm.01532-24}
}
Kostenlos starten →